The Mood Study
The study drug is a potential new treatment for Major Depressive Disorder (MDD), which is one of the leading causes of disability in the world.
In this Phase 1 clinical trial, the study drug will be administered to healthy volunteers who do not have the disorder. The study drug can be administered as an oral solution or a capsule. It has been designed to act like a thyroid hormone, which influences metabolism and brain function. It is hoped that as a result, the study drug might improve symptoms of MDD.
While there are currently treatments available for MDD, a significant proportion of patients don’t get adequate relief from existing treatment options. It is important that new treatments are developed that hopefully provide relief for those whose condition is resistant to current treatments.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!